- Additional information
|Synonyms||Briviact;UCB-34714;brivaracetam;BrivaracetamL;API-Anti Epilepsy;Brivaracetam fandachem;brivaracetam USP/EP/BP;UCB 34714|
What is Brivaracetam?
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. It provides a new monotherapy treatment option for epilepsy patients 16 years of age and older who suffer partial-onset seizures, which can be initiated at a therapeutic dose on day one.
Packing material for different products: Aluminium foil bag, HDPE bottle, Iron drum, or according to require
Shelf Life: 2 Years from production date
DMSO (Slightly), Methanol (Slightly)